| |
FDA Approval Activities for this Drug
Naropin (ropivacaine HCl) Injection,Rx AstraZeneca L.P. NDA 20-533/S-002 11/2/00
Naropin Indication:for the production of local or regional anesthesia for surgery and for acute pain management. Naropin (ropivacaine HCl) Injection, AstraZeneca, Labeling Revision
For the latest approval information and links for this API, please see the main page.
|